B. MDM2 and p53 expression in DLBCL patients with or without p53 overexpression
| . | p53+ . | p53– . | Mean p53 expression (% cells) . |
|---|---|---|---|
| MDM2– patients | 79 | 204 | 19% |
| WT-p53/MDM2– | 32 | 183 | 9% |
| MUT-p53/MDM2– | 47 | 21 | 39% |
| MDM2+ patients | 103 | 88 | 28% |
| WT-p53/MDM2+ | 75 | 79 | 17% |
| MUT-p53/MDM2+ | 28 | 9 | 50% |
| . | p53+ . | p53– . | Mean p53 expression (% cells) . |
|---|---|---|---|
| MDM2– patients | 79 | 204 | 19% |
| WT-p53/MDM2– | 32 | 183 | 9% |
| MUT-p53/MDM2– | 47 | 21 | 39% |
| MDM2+ patients | 103 | 88 | 28% |
| WT-p53/MDM2+ | 75 | 79 | 17% |
| MUT-p53/MDM2+ | 28 | 9 | 50% |